Adherence to antiretrovirals among US women during and after pregnancy.
Adherence to antiretrovirals among US women during and after pregnancy.
复制标题
DOI:
10.1097/qai.0b013e31817bbe80
复制
发表时间:
2008-08-01
期刊:
影响因子:
--
通讯作者:
PACTG 1025 Protocol Team
中科院分区:
文献类型:
--
作者:
Bardeguez AD;Lindsey JC;Shannon M;Tuomala RE;Cohn SE;Smith E;Stek A;Buschur S;Cotter A;Bettica L;Read JS;PACTG 1025 Protocol Team
Antiretrovirals (ARVs) are recommended for maternal health and to reduce HIV-1 mother-to-child transmission, but suboptimal adherence can counteract its benefits. To describe antepartum and postpartum adherence to ARV regimens and factors associated with adherence. We assessed adherence rates among subjects enrolled in Pediatric AIDS Clinical Trials Group Protocol 1025 from August 2002 to July 2005 on tablet formulations with at least one self-report adherence assessment. Perfectly adherent subjects reported no missed doses 4 days before their study visit. Generalized estimating equations were used to compare antepartum with postpartum adherence rates and to identify factors associated with perfect adherence. Of 519 eligible subjects, 334/445 (75%) reported perfect adherence during pregnancy. This rate significantly decreased 6, 24, and 48 weeks postpartum [185/284 (65%), 76/118 (64%), and 42/64 (66%), respectively (P < 0.01)]. Pregnant subjects with perfect adherence had lower viral loads. The odds of perfect adherence were significantly higher for women who initiated ARVs during pregnancy (P < 0.01), did not have AIDS (P = 0.02), never missed prenatal vitamins (P < 0.01), never used marijuana (P = 0.05), or felt happy all or most of the time (P < 0.01). Perfect adherence to ARVs was better antepartum, but overall rates were low. Interventions to improve adherence during pregnancy are needed.